Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes

Federico Andreoli1, Alberto Del Rio2

  • 1Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum, University of Bologna, Via S. Giacomo 14, 40126 Bologna, Italy.

Insights

Epigenetic mechanisms, particularly histone modifications, are key in disease. Computer-aided molecular design aids in developing new drugs targeting these epigenetic processes for therapeutic benefits.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Epigenetic mechanisms, including histone post-translational modifications, are increasingly recognized for their roles in health and disease.
  • Histone modifications, catalyzed by specific enzyme families, regulate chromatin structure and gene expression.
  • Dysregulation of histone modifications is linked to various pathological conditions, notably cancer.

Purpose of the Study:

  • To review common histone modifications and their associated enzymes.
  • To highlight the application of computer-aided molecular design in epigenetic drug discovery.
  • To accelerate the development of novel pharmaceutical compounds targeting epigenetic pathways.

Main Methods:

  • Literature review of histone modifications and enzymes.
  • Analysis of computer-aided molecular design strategies.
  • Focus on structural information for target validation.

Main Results:

  • Characterization of numerous histone modifications and their regulatory enzymes.
  • Identification of epigenetic targets for drug development.
  • Demonstration of computer-aided molecular design's utility in pharmaceutical research.

Conclusions:

  • Epigenetic modifications are critical in disease pathogenesis.
  • Targeting epigenetic mechanisms offers promising therapeutic avenues.
  • Computational approaches are vital for advancing epigenetic drug discovery.